FLT3 and acute myeloid leukemia: The FMS-like tyrosine kinase 3 (FLT3) molecule, which is involved in cell differentiation and proliferation, is expressed in most AML cases, and the FLT3-ITD mutation, which is found in approximately 30% of AML cases, is one of the factors associated with a poor prognosis [59].